Advances and new frontiers for immunotherapy in colorectal cancer: Setting the stage for neoadjuvant success? N Sumransub, K Vantanasiri, A Prakash, E Lou Molecular Therapy-Oncolytics 22, 1-12, 2021 | 25 | 2021 |
Periostin regulates autophagy through integrin α5β1 or α6β4 and an AKT‐dependent pathway in colorectal cancer cell migration S Thongchot, E Singsuksawat, N Sumransub, A Pongpaibul, ... Journal of Cellular and Molecular Medicine 24 (21), 12421-12432, 2020 | 23 | 2020 |
Crosstalk between tumor-infiltrating immune cells and cancer-associated fibroblasts in tumor growth and immunosuppression of breast cancer J Soongsathitanon, P Jamjuntra, N Sumransub, S Yangngam, ... Journal of Immunology Research 2021, 2021 | 17 | 2021 |
Breast cancer stem cell RNA‑pulsed dendritic cells enhance tumor cell killing by effector T cells N Sumransub, N Jirapongwattana, P Jamjuntra, S Thongchot, ... Oncology Letters 19 (3), 2422-2430, 2020 | 17 | 2020 |
Putting function back in dysfunction: Endothelial diseases and current therapies in hematopoietic stem cell transplantation and cellular therapies N Sumransub, N El Jurdi, W Chiraphapphaiboon, JE Maakaron Blood Reviews 51, 100883, 2022 | 7 | 2022 |
Checkpoint inhibitor‐based salvage regimens prior to autologous stem cell transplant improve event‐free survival in relapsed/refractory classic Hodgkin lymphoma SH Desai, MA Spinner, K David, V Bachanova, G Goyal, B Kahl, K Dorritie, ... American journal of hematology 98 (3), 464-471, 2023 | 6 | 2023 |
High proliferating regulatory T cells post-transplantation are associated with poor survival in lymphoma patients treated with autologous hematopoietic stem cell transplantation N Sumransub, Q Cao, R Wangen, C Brunstein, JS Miller, V Bachanova Transplantation and Cellular Therapy 28 (4), 184. e1-184. e8, 2022 | 6 | 2022 |
Novel salvage regimens lead to better response and survival in relapsed refractory classic Hodgkin lymphoma after autologous stem cell transplant SH Desai, MA Spinner, KA David, V Bachanova, G Goyal, J Azzi, ... Blood 138, 878, 2021 | 5 | 2021 |
Sarcopenia predicts inferior progression-free survival in lymphoma patients treated with autologous hematopoietic stem cell transplantation N Sumransub, Q Cao, M Juckett, B Betts, S Holtan, N El Jurdi, M Hu, ... Transplantation and Cellular Therapy 29 (4), 263. e1-263. e7, 2023 | 3 | 2023 |
Efficacy of CD19 directed therapies in large B-cell lymphoma (LBCL) relapsing after chimeric antigen receptor (CAR) T-cell therapy M Iqbal, A Khurana, J Chavez, AC Rosenthal, Z Li, E Craver, S Aditi, ... Blood 140 (Supplement 1), 10396-10398, 2022 | 3 | 2022 |
Outcomes of classic Hodgkin lymphoma, relapsed within one year of diagnosis, in the era of novel agents. S Desai, MA Spinner, KA David, V Bachanova, G Goyal, R Saba, ... Journal of Clinical Oncology 40 (16_suppl), 7515-7515, 2022 | 3 | 2022 |
Overall survival of patients with cHL who progress after autologous stem cell transplant: results in the novel agent era SH Desai, MA Spinner, AM Evens, A Sykorova, V Bachanova, G Goyal, ... Blood Advances 7 (23), 7295-7303, 2023 | 2 | 2023 |
Severe hyperammonemia in chimeric antigen receptor T cells recipient—unusual differential diagnosis of encephalopathy syndrome N Sumransub, F He, D Weisdorf, CJ Billington Jr, A Aggarwal, B Miller, ... Bone marrow transplantation 57 (2), 286-288, 2022 | 2 | 2022 |
Overall survival in classic Hodgkin lymphoma pts who progress after autologous stem cell transplant in the era of novel agents SH Desai, M Spinner, AM Evens, V Bachanova, G Goyal, B Kahl, ... Hematological Oncology 41, 366-368, 2023 | 1 | 2023 |
Efficacy of brentuximab consolidation by metabolic response in an international real‐world cohort of classic Hodgkin lymphoma at high risk for progression after ASCT SH Desai, A Smith, M Spinner, A Sykorova, V Bachanova, AM Evens, ... Hematological Oncology 41, 361-362, 2023 | 1 | 2023 |
Sarcopenia Predicts Inferior Progression Free Survival in Lymphoma Patients Treated with Autologous Hematopoietic Stem Cell Transplantation N Sumransub, Q Cao, M Juckett, BC Betts, SG Holtan, N El Jurdi, M Hu, ... 2022 Tandem Meetings| Transplantation & Cellular Therapy Meetings of ASTCT …, 2022 | 1 | 2022 |
Multiple malignant tumors in a patient with familial chordoma, a case report N Sumransub, P Murugan, S Marette, DR Clohisy, KM Skubitz BMC Medical Genomics 14 (1), 213, 2021 | 1 | 2021 |
A case of AL amyloidosis presenting with refractory ventricular fibrillation N Angsubhakorn, A Agdamag, N Sumransub, P Velangi, R Freund, ... Respiratory Medicine Case Reports 32, 101349, 2021 | 1 | 2021 |
Kikuchi-Fujimoto disease mimicking T-cell lymphoma after COVID-19 vaccination N Sumransub, V Bachanova, MA Linden American Journal of Clinical Pathology, aqae016, 2024 | | 2024 |
Identification of HLA‐restricted Cytotoxic T Lymphocyte Epitopes of B Cell Maturation Antigen as Promising Peptide Vaccine Candidates for Preventive and Therapeutic Strategies … W Chiraphapphaiboon, P Luangwattananun, T Chieochansin, ... Advanced Therapeutics 7 (2), 2300208, 2024 | | 2024 |